Inflammatory rather than infectious insults play a role in exocrinetissuedamageinamousemodel for coxsackievirus B4-induced pancreatitis

Journal of Pathology

Volumn 217, Issue 5, 2009, Pages 633-641

  De Palma, Armando M ^a   Thibaut, Hendrik J ^a   Li, Sandra ^a   Van Aelst, Ilse ^a   Dillen, Chris ^a   Swinnen, Melissa ^b   Verbeken, Erik ^b   Neyts, Johan ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

COAM; Coxsackievirus; Gel zymography; Gelatinase B; MMP 9; Pancreatitis; Viral

Indexed keywords

AMYLASE; CARBOXYLIC ACID DERIVATIVE; CHLORITE OXIDIZED OXYAMYLOSE; GELATINASE B; IMMUNOMODULATING AGENT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; DISEASE SEVERITY; EXPERIMENTAL MODEL; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS INJURY; PANCREATITIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VIRUS REPLICATION; VIRUS TITRATION;

AMYLOSE; ANIMALS; CHEMOTAXIS, LEUKOCYTE; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; MALE; MATRIX METALLOPROTEINASE 9; MICE; NEUTROPHIL INFILTRATION; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; VIRUS REPLICATION;

EID: 64549095279     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2501     Document Type: Article

References (56)

1. Minor PD, Morgan-Capner P, Muir P. Enteroviruses. In Principles and Practice of Clinical Virology, Zuckerman AJ, Banatvala E, Pattison JR (eds). Wiley: Chichester, 2000; 427-449.
2. Vuorinen T, Kallajoki M, Hyypia T, Vainionpaa R. Coxsackievirus B3-induced acute pancreatitis: analysis of histopatholog- ical and viral parameters in a mouse model. Br J Exp Pathol 1989;70(4):395-403.
3. Yap IS, Giddings G, Pocock E, Chantler JK. Lack of islet neogenesis plays a key role in β cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol 2003;84(pt 11):3051-3068.
4. Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 2006;80(11):5637-5643.
5. Rasilainen S, Ylipaasto P, Roivainen M, Bouwens L, Lap- atto R, Hovi T, et al. Mechanisms of f cell death during restricted and unrestricted enterovirus infection. JMedVirol 2004;72(3):451-461.
6. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002;45(5):693-702.
7. Frisk G, Diderholm H. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int J Exp Diabetes Res 2000;1(3):165-175.
8. Dotta F, Censini S, van Halteren AG, Marselli L, Masini M, Dionisi S, et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007;104(12):5115-5120.
9. Ramsingh AI, Lee WT, Collins DN, Armstrong LE. Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J Virol 1997;71(11):8690-8697.
10. See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J Infect Dis 1995;171(5):1131-1138.
11. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, et al. IL-12 protects against cox- sackievirus B3-induced myocarditis by increasing IFN-Υ and macrophage and neutrophil populations in the heart. J Immunol 2005;174(1):261-269.
12. Vella C, Festenstein H. Coxsackievirus B4 infection of the mouse pancreas: the role of natural killer cells in the control of virus replication and resistance to infection. J Gen Virol 1992;73(pt 6):1379-1386.
13. Zaragoza C, Ocampo CJ, Saura M, Bao C, Leppo M, Lafond- Walker A, et al. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 1999;163(10):5497-5504.
14. Huhn MH, Hultcrantz M, Lind K, Ljunggren HG, Malmberg KJ, Flodstrom-Tullberg M. IFN-Υ production dominates the early human natural killer cell response to Coxsackievirus infection. Cell Microbiol 2008;10(2):426-436.
15. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvet- nick N. Pancreatic expression of interferon-y protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000;6(6):693- 697.
16. Chow LH, Beisel KW, McManus BM. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992;66(1):24-31.
17. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993;68(2):159-169.
18. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979;300(21):1173-1179.
19. Claes P, Billiau A, De Clercq E, Desmyter J, Schonne E, Vanderhaeghe H, et al. Polyacetal carboxylic acids: a new group of antiviral polyanions. JVirol 1970;5(3):313-320.
20. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Man- davilli U, Knoefel WT, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215(1):44-56.
21. Descamps FJ, Martens E, Opdenakker G. Analysis of gelatinases in complex biological fluids and tissue extracts. Lab Invest 2002;82(11): 1607-1608.
22. Brilot F, Geenen V, Hober D, Stoddart CA. Coxsack- ievirus B4 infection of human fetal thymus cells. JVirol 2004;78(18):9854-9861.
23. Ostrowski SE, Reilly AA, Collins DN, Ramsingh AI. Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis. JVirol2004;78(15):8229-8237.
24. De Palma AM, Verbeken E, Van Aelst I, Van den Steen PE, Opdenakker G, Neyts J. Increased gelatinase B/matrix metallopro- teinase 9 (MMP-9) activity in a murine model of acute coxsack- ievirus B4-induced pancreatitis. Virology 2008.
25. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001;69(6):851-859.
26. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330(17):1198-1210.
27. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008;371(9607):143-152.
28. Huber S, Ramsingh AI. Coxsackievirus-induced pancreatitis. Viral Immunol 2004;17(3):358-369.
29. Chrysos G, Kokkoris S, Protopsaltis J, Korantzopoulos P, Gian- noulis G. Coxsackievirus infection associated with acute pancreatitis. J Pancreatology 2004;5(5):384-387.
30. Hindersson M, Orn A, Harris RA, Frisk G. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance. Arch Virol 2004;149(10):1985-2000.
31. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. JMed Virol 2000;62(1):70-81.
32. Ramsingh AI. CVB-induced pancreatitis and alterations in gene expression. Curr Top Microbiol Immunol 2008;323:241-258.
33. Billiau A, Muyembe JJ, De Somer P. Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice. Appl Microbiol 1971;21(4):580-584.
34. Potvin DM, Metzger DW, Lee WT, Collins DN, Ramsingh AI.Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. JVirol 2003;77(15):8272-8279.
35. Kim EO, Joo CH, Ye JS, Jun EJ, Lee HS, Min WK, et al. Quantitative analysis of viral RNA in the murine heart and pancreas with different concentration of coxsackievirus B3. Intervirology 2006;49(4):192- 199.
36. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.
37. Horwitz MS, Krahl T, Fine C, Lee J, Sarvetnick N. Protection from lethal coxsackievirus-induced pancreatitis by expression of y-interferon. JVirol 1999;73(3):1756-1766.
38. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whit- ton JL. The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 1999;155(4):1205-1215.
39. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whit-ton JL. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 2000;271(2):276-288.
40. Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, Asensio VC, et al. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am JPathol 1998;153(2):417-428.
41. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Takaku F, et al. Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 1991;84(2):788-795.
42. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Yazaki Y. Evidence of perforin-mediated cardiac myocyte injury in acute murine myocarditis caused by Coxsackie virus B3. J Pathol 1993;170(1):53-58.
43. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res 1998;67(6):619-624.
44. Ellis TN, Beaman BL. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 2004;112(1):2-12.
45. Wang SZ, Forsyth KD. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 2000;5(1):1-10.
46. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22(10):571-579.
47. Vonlaufen A, Apte MV, Imhof BA, Frossard JL. The role of inflammatory and parenchymal cells in acute pancreatitis. J Pathol 2007;213(3): 239-248.
48. Osman MO, Lausten SB, Jakobsen NO, Kristensen JU, Deleu- ranB, LarsenCG, et al. Graded experimental acute pancreatitis: monitoring of a renewed rabbit model focusing on the production of interleukin-8 (IL-8) and CD11b/CD18. Eur J Gastroenterol Hepatol 1999;11(2):137-149.
49. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-α. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100(7):1853-1862.
50. Keck T, Balcom JH, Fernandez-del Castillo C, Antoniu BA, Warshaw AL. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002;122(1):188-201.
51. BhatiaM, SalujaAK, HofbauerB, Lee HS, FrossardJL, Steer ML. The effects of neutrophil depletion on a completely noninvasive model ofacute pancreatitis-associated lung injury. Int J Pancreatol 1998;24(2):77-83.
52. Chen X, Ji B, Han B, E rnst SA, Simeone D, Logsdon CD. NF- ΚB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002;122(2):448-457.
53. Frossard JL, Saluja A, Bhagat L, Lee HS, Bhatia M, Hofbauer B,et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999;116(3):694-701.
54. Hayashi T, Ishida Y, Kimura A, Iwakura Y, Mukaida N, Kondo T. IFN-γ protects cerulein-induced acute pancreatitis by repressing NF-ΚB activation. J Immunol 2007;178(11):7385-7394.
55. Pastor CM, Vonlaufen A, Georgi F, Hadengue A, Morel P, Frossard JL. Neutrophil depletion- but not prevention of Kupf- fer cell activation- decreases the severity of cerulein-induced acute pancreatitis. World J Gastroenterol 2006;12(8):1219-1224.
56. Triantafilou K, Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through tolllike receptor 4. JVirol 2004;78(20):11313-11320.